A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer
Titel:
A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer
Auteur:
Rugo, Hope S. Jo Chien, A. Franco, Sandra X. Stopeck, Alison T. Glencer, Alexa Lahiri, Soumi Arbushites, Michael C. Scott, Janet Park, John W. Hudis, Clifford Nulsen, Ben Dickler, Maura N.